Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP science news

Show

From To
Studies highlight complex questions about how communities will respond to PrEP

Two consecutive sessions at the 19th International AIDS Conference (AIDS 2012) in Washington DC highlighted some of the complexities of translating exciting research findings about pre-exposure prophylaxis

Published
25 July 2012
By
Kelly Safreed-Harmon
High levels of adherence reached in two PrEP studies, but resistance cases show need for rigorous testing before prescribing

Two studies of pre-exposure prophylaxis (PrEP) in heterosexuals in Africa, both of which reported significant efficacy in preventing HIV infection last year, published their final results in the

Published
20 July 2012
By
Gus Cairns
The road to PrEP: trials, regulation and roll-out

Within the next three years, up to 33,000 people may take part in 22 different studies worldwide to demonstrate the feasibility, or otherwise, of pre-exposure prophylaxis

Published
25 June 2012
By
Gus Cairns
Study identifies characteristics of gay men who may be suitable for intermittent PrEP

Older, better-educated gay men who use sexual networking sites and have sex outside the context of committed relationships may be appropriate targets for intermittent pre-exposure prophylaxis (PrEP), US

Published
06 June 2012
By
Michael Carter
Kenyan heterosexual couples want a choice of antiretroviral prevention methods

Approximately 40% of HIV-positive people in a stable relationship with an HIV-negative person in Kenya have reservations about starting antiretroviral therapy early for the purposes of prevention, investigators

Published
23 May 2012
By
Michael Carter
Poor knowledge of HIV PrEP among MSM in Beijing, but high interest

Few gay and other men who have sex with men (MSM) in Beijing have heard of pre-exposure prophylaxis (PrEP), investigators report in PLoS One. Despite this, over two-thirds

Published
03 May 2012
By
Michael Carter
PrEP acceptable to UK gay men, studies find

Pre-exposure prophylaxis (PrEP) would be an acceptable HIV prevention strategy for large numbers of gay, bisexual and other men who have sex with men in major UK

Published
21 April 2012
By
Roger Pebody
Contraceptive requirement may have compromised FEM-PrEP study

A requirement that all participants take hormonal contraceptives may have been what led to the disappointing failure of a study of pre-exposure prophylaxis (PrEP) targeted at single women,

Published
16 April 2012
By
Gus Cairns
Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

The first trial in humans of an injectable, once-a-month formulation of an HIV drug has found that drug levels were maintained at a level that should in

Published
07 March 2012
By
Gus Cairns
Four doses of PrEP a week may be enough to protect

Further testing of drug levels in the blood and immune cells of gay men participating in the iPrEx trial of tenofovir/FTC (Truvada) pre-exposure prophylaxis (PrEP) has

Published
06 March 2012
By
Gus Cairns

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.